Initial Results of Catheter-Directed Ultrasound-Accelerated Thrombolysis for Thromboembolic Obstructions of the Aortofemoral Arteries: A Feasibility Study
Authors:
- A. Marjolein SchrijverASA. Marjolein Schrijver
- Michel M. P. J. ReijnenMRMichel M. P. J. Reijnen
- Jacques A. van OostayenJOJacques A. van Oostayen
- Arjan W. J. HoksbergenAHArjan W. J. Hoksbergen
- Rutger J. LelyRLRutger J. Lely
- Marc van LeersumMLMarc van Leersum
- Jean-Paul P. M. de VriesJVJean-Paul P. M. de Vries
- 2 May 2011
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 35 (2) , 279-285
Abstract
Purpose This article reports the 30-day technical and clinical outcome of ultrasound (US)-accelerated thrombolysis in patients with aortofemoral arterial thromboembolic obstructions. Methods A prospective cohort study was conducted from December 2008 to December 2009 of patients who were treated with US-accelerated thrombolysis for thromboembolic obstructions of aortofemoral arteries or bypasses. Urokinase was infused in a dosage of 100,000 IU per hour. Twice daily, a control angiography was performed. Thirty-day follow-up consisted of duplex scanning, combined with magnetic resonance angiography. Results The study included 21 consecutive patients (20 men; median age, 66 (range, 52–80) years) with 24% artery versus 76% bypass occlusions. Median duration of symptoms was 11 (range, 7–140) days. Median occlusion length was 32 (range, 6–80) cm. In 20 patients (95%), an US-accelerated thrombolysis catheter could be successfully placed. In one patient, placement of an US-accelerated thrombolysis catheter was technically not feasible, and therefore a standard catheter was placed. Median thrombolysis time was 26.5 (range, 8.5–72) hours. Complete thrombolysis (>95% lysis of thrombus) was achieved in 20 patients; in 9 patients within 24 hours. Median ankle-brachial index (ABI) increased from 0.28 (range, 0–0.85) to 0.91 (range, 0.58–1.35). One patient had a thromboembolic complication and needed surgical intervention. No hemorrhagic complications, and no deaths occurred. At 30-day follow-up, 17 of 21 patients (81%) had a patent artery or bypass. Conclusions This feasibility study showed a high technical success rate of US-accelerated thrombolysis for aortofemoral arterial obstructions. US-accelerated thrombolysis led to complete lysis within 24 hours in almost half of patients, with a low 30-day major complication rate.Keywords
This publication has 24 references indexed in Scilit:
- Behandlung akuter Okklusionen von femoropoplitealen Bypässen: Vergleich der mechanischen Rotationsthrombektomie mit der ultraschallgestützten LyseRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2008
- The Interventional Management of Stroke (IMS) II StudyStroke, 2007
- Ultrasound and thrombolysisVascular Medicine, 2001
- A Comparison of Recombinant Urokinase with Vascular Surgery as Initial Treatment for Acute Arterial Occlusion of the LegsNew England Journal of Medicine, 1998
- Ultrasound enhancement of rabbit femoral artery thrombolysisCardiovascular Surgery, 1997
- High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: An in vitro and in vivo studyJACC, 1994
- Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE TrialAnnals of Surgery, 1994
- Ultrasound enhancement of thrombolysis and reperfusion in vitroJACC, 1993
- Enhancement of fibrinolysis in vitro by ultrasound.Journal of Clinical Investigation, 1992
- Thrombus age and tissue plasminogen activator mediated thrombolysis in ratsThrombosis Research, 1989